The Global CAR-T Cell Therapy Market was valued at US$ 2.15 billion in 2024 and is projected to reach US$ 15.8 billion by 2033, registering a CAGR of 23.1% during the forecast period 2025–2033. The market is expanding rapidly due to rising demand for personalized cancer treatments and innovations in immunotherapy. Advances in genetic engineering, cell modification technologies, and...